Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,257,088 papers from all fields of science
Search
Sign In
Create Free Account
UCL 2077
Known as:
UCL-2077
, UCL2077
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
3-(triphenylmethylaminomethyl)pyridine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Inhibition of the slow afterhyperpolarization restores the classical spike timing-dependent plasticity rule obeyed in layer 2/3 pyramidal cells of the prefrontal cortex.
A. Zaitsev
,
R. Anwyl
Journal of Neurophysiology
2012
Corpus ID: 14835957
The induction of long-term potentiation (LTP) and long-term depression (LTD) of excitatory postsynaptic currents was investigated…
Expand
2012
2012
Rapport de mission de janvier 2012; PIC Bonne gouvernance (UCG-UCL-ULg)
Pierre Verjans
2012
Corpus ID: 127754480
2011
2011
Applications of multi-cluster endogenous technology learning in TIAM-UCL
G. Anandarajah
2011
Corpus ID: 58861189
2010
2010
a slow AHP in 1 thalamic paraventricular nucleus neurons : a novel target for orexin receptors 2 3
Miloslav Kolaj Li Zhang
,
L. Renaud
2010
Corpus ID: 9242015
18 Thalamic paraventricular nucleus (PVT) neurons exhibit a post-burst apamin-resistant 19 slow afterhyperpolarization (sAHP…
Expand
2006
2006
Enhancement of Hippocampal Pyramidal Cell Excitability by the Novel Selective Slow-Afterhyperpolarization Channel Blocker 3-(Triphenylmethylaminomethyl)pyridine (UCL2077)
M. Shah
,
Mazyar Javadzadeh-Tabatabaie
,
D. C. Benton
,
C. Ganellin
,
D. G. Haylett
Molecular Pharmacology
2006
Corpus ID: 7708803
The slow afterhyperpolarization (sAHP) in hippocampal neurons has been implicated in learning and memory. However, its precise…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE